US 11786606
Site-specific quantitation of drug conjugations
granted A61KA61K47/6815A61K47/6817
Quick answer
US patent 11786606 (Site-specific quantitation of drug conjugations) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K47/6815, A61K47/6817, A61K47/6889